Source: Annual Congress 2012 - Fungal, viral and other infections
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Tamai, R. Tachikawa, T. Kawamura, K. Monden, T. Matsumoto, J. Takeshita, K. Tanaka, K. Nagata, K. Otsuka, A. Nakagawa, K. Otsuka, K. Tomii (Kobe, Japan). Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients. Eur Respir J 2012; 40: Suppl. 56, 1919

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Clinical manifestations and a prognostic factor of pneumocystis pneumonia without HIV infection Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 Clinical and radiological features of pneumocystis pneumonia in immunocompromised non-HIV patients Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia Source: Eur Respir J 2016; 48: 797-807 Year: 2016 Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia Source: ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019 Year: 2020 Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation Source: Eur Respir J 2010; 35: 927-929 Year: 2010 Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Clinical features and prognostic factors in elderly patients with aspiration pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Clinical patterns of Pneumocystis Jirovecii in HIV and non-HIV patients Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Prognostic factors of mortality in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 239s Year: 2003 Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006 Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients Source: Eur Respir J 2001; 17: 87-93 Year: 2001 Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Prognosis of pneumocystis jirovecii pneumonia in non-HIV patients Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Clinical features of COVID-19 pneumonia in elderly patients Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Usefulness of alveoloscopy in the diagnosis pf Pneumocystis jiroveci pneumonia in HIV+ patients Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Clinical epidemiology of pneumonia in hemodialysis patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 The assessment of prognostic rules in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Risk factors of paediatric community-acquired pneumonia Source: Eur Respir J 2011; 37: 724-725 Year: 2011